Skip to content

Skin Disease in Methamphetamine Abuse

Skin Disorders in Patients Using Methamphetamine

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05971043
Enrollment
500
Registered
2023-08-02
Start date
2023-08-03
Completion date
2024-09-20
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methamphetamine Abuse

Brief summary

1\. To detect the skin diseases in patients using methamphetamine

Detailed description

Methamphetamine is a stimulant drug that associated with a broad spectrum of health conditions, include addiction, mental health disorders, and overdose. The Drug Enforcement Agency (DEA) classifies it as a Schedule II drug. This means that the drug has a high potential for misuse. The drug is also called crystal meth, ice, and blue. Methamphetamine use has increased in Egypt especially in upper Egypt. Literature on cutaneous manifestations among methamphetamine users is limited, although cellulitis, delusion of parasitosis (DOP), hyperhidrosis, formication and prurigo nodularis (PN) have been attributed to methamphetamine users. While the relationship between skin lesions and substance use in not fully defined, there is some evidence that points to the development of these itchy, red lesion also known as meth sore after meth use. Meth sores often look like small round red patches on your skin, they can often be confused with acne when they appear on the face or a rash when they appear on other parts of the body. Meth sores form as a result of heavy meth misuse. other signs of meth abuse at the stage where sores likely to develop include: * Weight loss * Paranoia * Hallucinations * Aggressive behavior * Being easily distracted * Tooth and gum decay * Changes in brain structure

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 75 Years

Inclusion criteria

* Patients using methamphetamine

Exclusion criteria

* 1\. Pregnant and lactating patients. 2. Patients with chronic diseases

Design outcomes

Primary

MeasureTime frameDescription
skin disorders in patients using methamphetaminebaselinequestionnaire-based study To detect the skin diseases and manifestation appears in patients using methamphetamine

Contacts

Primary Contactasmaa mohamed, master
amelnakeeb@gmail.com+201097507017
Backup Contactsahar ismail, professor
saharsotohy@yahoo.com01008899446

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026